高扬（Frank ）博士，Ph.D. & EMBA，PharmaGo Consulting 创始人兼 CEO，拥有近 20 年制药行业管理与研发经验。曾任职于中国国家药品监督管理局、礼来、亚盛医药等机构，深耕创新药研发、监管策略、质量管理等领域，主导多款基因细胞治疗产品全球开发并获 IND 批准。现聚焦 AI 驱动的药物研发与监管智能系统搭建，同时担任多行业协会委员及高校导师，为行业提供资深咨询与战略支持。
Dr. Yang Gao (Frank), Ph.D. & EMBA, is the Founder and CEO of PharmaGo Consulting with nearly 20 years of experience in pharmaceutical management and R&D. He has held key roles at NMPA, Eli Lilly, Ascentage Pharm, etc., specializing in innovative drug R&D, regulatory strategy, and quality management. He led the global development of multiple gene and cell therapy products with IND approvals. Currently, he focuses on building AI-powered drug R&D and regulatory intelligence systems. He also serves as a committee member of industry associations and university mentor, providing senior consulting and strategic support to the sector.
高杨博士 Dr. Yang Gao
企业特聘教授
PharmaGo Consulting 创始人兼CEO
Industry Honorary Professor
Founder and CEO of PharmaGo Consulting
高扬（Frank ）博士，Ph.D. & EMBA，PharmaGo Consulting 创始人兼 CEO，拥有近 20 年制药行业管理与研发经验。曾任职于中国国家药品监督管理局、礼来、亚盛医药等机构，深耕创新药研发、监管策略、质量管理等领域，主导多款基因细胞治疗产品全球开发并获 IND 批准。现聚焦 AI 驱动的药物研发与监管智能系统搭建，同时担任多行业协会委员及高校导师，为行业提供资深咨询与战略支持。
Dr. Yang Gao (Frank), Ph.D. & EMBA, is the Founder and CEO of PharmaGo Consulting with nearly 20 years of experience in pharmaceutical management and R&D. He has held key roles at NMPA, Eli Lilly, Ascentage Pharm, etc., specializing in innovative drug R&D, regulatory strategy, and quality management. He led the global development of multiple gene and cell therapy products with IND approvals. Currently, he focuses on building AI-powered drug R&D and regulatory intelligence systems. He also serves as a committee member of industry associations and university mentor, providing senior consulting and strategic support to the sector.